Clinical Trial 15274

Knoxville, TN 37920


Study Summary:

A phase 3 research study to evaluate the efficacy, safety, and tolerability of an investigational medicine in the treatment of patients with diarrhea-predominant irritable bowel syndrome.


Qualified Participants Must:

• Be 18-80 years of age
• Be diagnosed with IBS or IBS-d


Qualified Participants May Receive:

Compensation for time and travel may be provided to those who qualify.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.